LinkedIn icon
e-mail icon
Rajesh Patel, Ph.D.'s picture

An acquisition, and Ad campaign and Promising Trial Results - Weekly Review for April 11

An acquisition, an ad campaign, and promising trial results, let's go over the stories we've been watching, commenting on, and in some cases, trading, this week.

Questcor (NASDAQ:QCOR)

Questcor is being acquired by Mallinckrodt for $5.6 billion. Read the article for details.

Ironwood Pharmaceuticals (NASDAQ:IRWD)

Ironwood is starting TV ads for Linzess. Read the article to find out how this should affect sales over time.

Merck (NYSE:MRK)

Merck reported positive Hepatitis C trial results. Read the article for details on which genotypes were helped and how this stacks up with the new gold-standard for HCV treatment.

 

To read the rest of our weekly review please sign up below and then confirm your signup in response to our email. Once you confirm your signup, we'll send you a link to the full Weekly Review.

 

Join our Free List

 

Red Acre Investments helps you Get Ahead of the Curve by providing analysis on stocks facing binary events. Sign up below to get our free email publication. Each email is packed with analysis and tips that help you become a better investor.

Join our Free List

 

Red Acre Investments helps you Get Ahead of the Curve by providing analysis on stocks facing binary events. Sign up below to get our free email publication. Each email is packed with analysis and tips that help you become a better investor.